Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ingredion (INGR) EBT (2016 - 2025)

Ingredion (INGR) has disclosed EBT for 17 consecutive years, with $207.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 36.18% year-over-year to $207.0 million, compared with a TTM value of $974.0 million through Dec 2025, up 4.62%, and an annual FY2025 reading of $974.0 million, up 4.62% over the prior year.
  • EBT was $207.0 million for Q4 2025 at Ingredion, down from $241.0 million in the prior quarter.
  • Across five years, EBT topped out at $276.0 million in Q1 2024 and bottomed at -$188.0 million in Q1 2021.
  • Average EBT over 5 years is $183.0 million, with a median of $200.5 million recorded in 2021.
  • The sharpest move saw EBT crashed 238.24% in 2021, then soared 199.47% in 2022.
  • Year by year, EBT stood at $78.0 million in 2021, then skyrocketed by 58.97% to $124.0 million in 2022, then soared by 41.94% to $176.0 million in 2023, then dropped by 13.64% to $152.0 million in 2024, then soared by 36.18% to $207.0 million in 2025.
  • Business Quant data shows EBT for INGR at $207.0 million in Q4 2025, $241.0 million in Q3 2025, and $259.0 million in Q2 2025.